Renee Maria Saliby: Discussing a huge clinical unmet – non-clear cell RCC
Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana-Farber Cancer Institute, shared a post by GU Oncology Now on X, adding:
“It was an honor to be part of my first roundtable with Tian Zhang and Shahla Bari.
Discussing a huge clinical unmet: non-clear cell RCC.
Special thanks to our exceptional moderator, Laurence Albiges for guiding the discussion.”
Quoting GU Oncology Now‘s post:
“Don’t miss the third installment of our round table with Laurence Albiges, Renee Maria Saliby, Tian Zhang and Shahla Bari, highlight recent advancements in combination therapies for non-clear cell renal cell carcinoma (nccRCC).
Watch Here.”
Evolution of Combination Therapy in nccRCC, Papillary Subtype
By Laurence Albiges, Renée Saliby, Tian Zhang, Shahla Bari
Proceed to the video attached to the post.
Source: Renee Maria Saliby/X and GU Oncology Now/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023